MedTrace Logo

Antabuse in Severe Alcoholism: an Open Controlled Study

NCT00431262 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-03-05

No results posted yet for this study

Summary

Newly detoxified alcoholics (N=60) are randomised to either antabuse (disulfiram) treatment or the control group for a total of 6 months.All patients will receive cognitive behavioural treatment in groups. The hypothesis to be tested is that more of the patients who receive antabuse (disulfiram) will be alcohol free during the 6 months treatment period compared to the control group. The trial is open.

Conditions

  • Alcoholism

Interventions

DRUG

antabuse (disulfiram)

Sponsors & Collaborators

  • Psykiatrisk Center Gentofte

    lead OTHER

Principal Investigators

  • Jakob Ulrichsen, MD, ph.d. · Psykiatrisk Center Gentofte

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2009-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00431262 on ClinicalTrials.gov